Modelling Negative Symptom Domains Neurobiology: Protocol for an Observational Transdiagnostic, Translational Study (Preprint)
Authors:
- Dan Cătălin OpreaDODan Cătălin Oprea
- Ilinca UntuIUIlinca Untu
- Diana-Sabina VieruDVDiana-Sabina Vieru
- Camelia DascăluCDCamelia Dascălu
- Helene SpeyerHSHelene Speyer
- Cristina DobreCDCristina Dobre
- Ohad GreenOGOhad Green
- Romeo Petru DobrinRomeo Petru Dobrin
- Michael DavidsonMDMichael Davidson
- Jonathan RabinowitzJRJonathan Rabinowitz
- Bogdan Ionel TambaBTBogdan Ionel Tamba
Preprint
- 24 January 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Negative symptoms (NS) such as anhedonia, avolition, asociality, blunted affect and alogia are associated with poor functional outcomes in psychiatric and neurological disorders and are an unmet treatment need. OBJECTIVE This protocol describes the design of an observational, single-center study aimed at characterizing negative symptoms across a transdiagnostic sample of individuals with mental disorders and related conditions, with a particular focus on avolition, its biological correlates, and associated neurocognitive and electrophysiological profiles. METHODS An observational study (involving no invasive procedures or drug administration other than a routine blood draw) has been designed to examine negative symptoms across psychiatric disorders. A total of 300 participants with a primary diagnosis of schizophrenia, bipolar disorder, unipolar depressive disorder, autism, or dementia will be recruited, with a target of at least 50 individuals in each diagnostic group. Consenting inpatients and outpatients will complete a battery of non-invasive behavioral and cognitive assessments, undergo electroencephalogram (EEG) recording, and provide blood samples for the assessment of polygenic risk scores. RESULTS The initial version of the study protocol was developed in February 2024. The finalized protocol was completed on August 5, 2024, and subsequently updated on January 11, 2025, to incorporate minor methodological clarifications. Participant recruitment and data collection commenced on July 1, 2024, and are ongoing at the time of manuscript submission. Data quality control and preliminary analyses are performed concurrently with data collection, while final statistical analyses and dissemination of results are planned following completion of the recruitment phase. CONCLUSIONS This study will provide critical insights into the characterization and underlying mechanisms of negative symptoms across psychiatric disorders. By focusing on avolition, reward processing, and their interaction with neurocognitive and social cognitive deficits, it will help identify potential biological and electrophysiological markers of negative symptoms. The findings may guide the development of more precise assessment tools and inform novel therapeutic strategies, with broad translational impact for improving outcomes in individuals with serious mental illness and related conditions.Keywords
This publication has 18 references indexed in Scilit:
- Estimating causal effects on psychological networks using item response theory.Psychological Methods, 2026
- Advancing the network theory of mental disorders: A computational model of panic disorder.Psychological Review, 2024
- The Brief negative Symptom Scale (BNSS): a systematic review of measurement propertiesSchizophrenia, 2023
- Testing the factor structure and measurement invariance of the Temporal Experience of Pleasure Scale in adolescents across time, gender, and race/ethnicity.Psychological Assessment, 2022
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Psychiatry, 2022
- Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment developmentSchizophrenia, 2021
- Negative symptoms of schizophrenia: new developments and unanswered research questionsThe Lancet Psychiatry, 2018
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet, 2016
- The reliability of the Personal and Social Performance scale – informing its training and usePsychiatry Research, 2016
- The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophrenia Research, 2004